Share of Cost, FDA Approves New Multiple Sclerosis Drug
The U.S. Food and Drug Administration (FDA) has approved a new drug called Tecfidera to treat adults with relapsing forms of multiple sclerosis (MS). For most MS patients, periods of worsening disability (relapses) are usually followed by recovery periods (remissions). Over time, these recovery periods may be incomplete, resulting in a progressive increase in disability. Tecfidera may help protect the body from infection and decrease the number of relapses.